This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08427/identifier/chemspider/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08427/identifier/chebi/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08427/identifier/pdb/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08427/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08427/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08427/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08427
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08427 n14:DB08427
dcterms:title
PREPHENIC ACID
adms:identifier
n8:99444898 n9:16666 n10:PRE n11:1028 n12:21537271 n13:DB08427
n3:IUPAC-Name
n4:271B5705-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B570B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B570A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5707-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5708-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5709-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5703-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5701-363D-11E5-9242-09173F13E4C5 n4:271B5704-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5702-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5711-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5712-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B570C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B570D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B570F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B570E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5710-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5717-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5719-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B571A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5716-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5715-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5718-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5706-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5713-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5714-363D-11E5-9242-09173F13E4C5